Ethical & OTC
EU legislation means pharmaceutical manufacturers are having to meet more stringent standards in the labelling of prescription drugs and OTC medicines. The EU’s Falsified Medicines Directive, which comes into force in 2019, will require that pharmaceutical product packaging carries a unique serial number to identify the products, and that the packaging seals should be tamper-evident.
Our range of labelstock products can combine high printability – even of fine fonts – with tamper-evident solutions, to help pharmaceutical manufacturers comply with these requirements.
- Optically clear
- Superior printability
Our range of labelstocks offer the following properties for OTC medicine packaging and identification:
Tamper-evident ‘VOID’ security labelstock – if the label is removed this labelstock’s tamper-indicating properties will instantly reveal a ‘VOID’ message.
Destructible labelstock for security marking – if anyone attempts to remove the label, the material will fracture easily, thwarting any attempt to re-apply it.
We also offer diverse solutions to help manufacturers meet ethical requirements in product and equipment labelling, including:
Ultra-low migration – improved safety for labelling of plastic molded pharmaceutical packaging.
Autoclavable – resistant to edge lifting on small diameter ampules, syringes and test tubes, compatible with gamma ray and alcohol sterilization methods. High transparency allows easy viewing of contents of container.
Extreme temperature resistance
- Cryogenic labelstock that can be directly immersed in liquid nitrogen at -196°C without risk of delamination
- Long-term abrasion, chemical and thermal shock resistant labelstock -when permanently fused to ceramic and glass surfaces, labels are heat resistant to 1250°C on ceramics and to 600°C on glassware